Takara Bio

Takara Bio Total Assets

Delisted

The Total Assets of Takara Bio (4974.T) as of Nov 21, 2026 is 125.33 B JPY. In the previous year, Total Assets was 121.25 B JPY — a change of 3.37% (higher).

Total Assets

125.33 BJPY

YoY

3.37%

Last updated:

Total Assets of Takara Bio is 2025 125.33 B JPY. Total Assets of Takara Bio was 2024 121.25 B JPY. It decreases by 3.37% higher compared to the previous year.

The Takara Bio Total Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Total Assets
Date
Total Assets
Jan 1, 2018
68.67 B JPY
Jan 1, 2019
71.04 B JPY
Jan 1, 2020
75.01 B JPY
Jan 1, 2021
89.75 B JPY
Jan 1, 2022
115.71 B JPY
Jan 1, 2023
129.20 B JPY
Jan 1, 2024
121.25 B JPY
Jan 1, 2025
125.33 B JPY
The Takara Bio Total Assets history
YEARTotal AssetsYoY
125.33 BJPY+3.37%
121.25 BJPY-6.15%
129.20 BJPY+11.66%
115.71 BJPY+28.93%
89.75 BJPY+19.65%
75.01 BJPY+5.59%
71.04 BJPY+3.45%
68.67 BJPY+2.27%
67.14 BJPY+0.83%
66.59 BJPY+0.25%
66.43 BJPY+6.28%
62.50 BJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Takara Bio Stock analysis

What does Takara Bio do? Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Takara Bio stock

Total Assets of Takara Bio is 125.33 B JPY in 2025.

Total Assets of Takara Bio changed from 121.25 B JPY to 125.33 B JPY, representing a 3.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Assets Takara Bio since 2006 – with annual values, charts, and detailed analysis.

Total assets represent everything a company owns, including cash, inventory, property, and intangible assets. It is a key measure of a company's size and resource base.

Total Assets's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Total Assets's Takara Bio historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Takara Bio

All Key Metrics — Takara Bio